Journal of Bone and Joint Infection (Oct 2024)
Efficacy of rezafungin in a case of <i>Candida</i> spondylodiskitis
Abstract
Rezafungin, which only requires weekly administration, is a potential candidate for difficult-to-treat infections that require long-term antimicrobial treatment, such as bone and joint infections. We report the first case of Candida glabrata spondylodiskitis successfully treated with 3 weeks of caspofungin followed by 10 weeks of rezafungin.